vs

Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and Turtle Beach Corp (TBCH). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $95.1M, roughly 1.7× Turtle Beach Corp). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 18.5%, a 52.7% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -34.9%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $13.1M).

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

The Turtle Beach Corporation is an American gaming accessory manufacturer based in San Diego, California. The company has roots dating back to the 1970s where it developed sound cards, MIDI synthesizers, and various audio software packages and network audio devices. The company began making gaming headsets in 2005.

STOK vs TBCH — Head-to-Head

Bigger by revenue
STOK
STOK
1.7× larger
STOK
$158.6M
$95.1M
TBCH
Growing faster (revenue YoY)
STOK
STOK
+3696.0% gap
STOK
3661.1%
-34.9%
TBCH
Higher net margin
STOK
STOK
52.7% more per $
STOK
71.2%
18.5%
TBCH
More free cash flow
STOK
STOK
$118.6M more FCF
STOK
$131.7M
$13.1M
TBCH

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
STOK
STOK
TBCH
TBCH
Revenue
$158.6M
$95.1M
Net Profit
$112.9M
$17.6M
Gross Margin
50.0%
Operating Margin
70.2%
22.0%
Net Margin
71.2%
18.5%
Revenue YoY
3661.1%
-34.9%
Net Profit YoY
528.0%
-12.6%
EPS (diluted)
$1.90
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STOK
STOK
TBCH
TBCH
Q4 25
$95.1M
Q3 25
$80.5M
Q2 25
$80.5M
Q1 25
$158.6M
$63.9M
Q4 24
$22.6M
$146.1M
Q3 24
$94.4M
Q2 24
$76.5M
Q1 24
$55.8M
Net Profit
STOK
STOK
TBCH
TBCH
Q4 25
$17.6M
Q3 25
$1.7M
Q2 25
$-2.9M
Q1 25
$112.9M
$-664.0K
Q4 24
$-10.5M
$20.1M
Q3 24
$3.4M
Q2 24
$-7.5M
Q1 24
$155.0K
Gross Margin
STOK
STOK
TBCH
TBCH
Q4 25
50.0%
Q3 25
37.4%
Q2 25
22.7%
Q1 25
36.6%
Q4 24
37.0%
Q3 24
36.2%
Q2 24
30.2%
Q1 24
31.8%
Operating Margin
STOK
STOK
TBCH
TBCH
Q4 25
22.0%
Q3 25
6.7%
Q2 25
-0.4%
Q1 25
70.2%
2.4%
Q4 24
-60.4%
16.0%
Q3 24
6.8%
Q2 24
-5.4%
Q1 24
-10.2%
Net Margin
STOK
STOK
TBCH
TBCH
Q4 25
18.5%
Q3 25
2.1%
Q2 25
-3.6%
Q1 25
71.2%
-1.0%
Q4 24
-46.4%
13.8%
Q3 24
3.6%
Q2 24
-9.8%
Q1 24
0.3%
EPS (diluted)
STOK
STOK
TBCH
TBCH
Q4 25
$0.86
Q3 25
$0.08
Q2 25
$-0.14
Q1 25
$1.90
$-0.03
Q4 24
$-0.15
$0.96
Q3 24
$0.16
Q2 24
$-0.35
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STOK
STOK
TBCH
TBCH
Cash + ST InvestmentsLiquidity on hand
$274.8M
$17.0M
Total DebtLower is stronger
$55.7M
Stockholders' EquityBook value
$350.1M
$128.5M
Total Assets
$406.9M
$269.1M
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STOK
STOK
TBCH
TBCH
Q4 25
$17.0M
Q3 25
$12.3M
Q2 25
$11.7M
Q1 25
$274.8M
$11.7M
Q4 24
$128.0M
$13.0M
Q3 24
$13.8M
Q2 24
$12.5M
Q1 24
$17.8M
Total Debt
STOK
STOK
TBCH
TBCH
Q4 25
$55.7M
Q3 25
$57.9M
Q2 25
$43.3M
Q1 25
$48.6M
Q4 24
$49.0M
Q3 24
$49.3M
Q2 24
$49.6M
Q1 24
$49.9M
Stockholders' Equity
STOK
STOK
TBCH
TBCH
Q4 25
$128.5M
Q3 25
$110.7M
Q2 25
$116.8M
Q1 25
$350.1M
$120.9M
Q4 24
$229.0M
$120.6M
Q3 24
$101.8M
Q2 24
$105.3M
Q1 24
$125.2M
Total Assets
STOK
STOK
TBCH
TBCH
Q4 25
$269.1M
Q3 25
$278.2M
Q2 25
$240.2M
Q1 25
$406.9M
$247.0M
Q4 24
$271.6M
$298.9M
Q3 24
$313.2M
Q2 24
$264.4M
Q1 24
$258.4M
Debt / Equity
STOK
STOK
TBCH
TBCH
Q4 25
0.43×
Q3 25
0.52×
Q2 25
0.37×
Q1 25
0.40×
Q4 24
0.41×
Q3 24
0.48×
Q2 24
0.47×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STOK
STOK
TBCH
TBCH
Operating Cash FlowLast quarter
$131.8M
$13.3M
Free Cash FlowOCF − Capex
$131.7M
$13.1M
FCF MarginFCF / Revenue
83.0%
13.8%
Capex IntensityCapex / Revenue
0.1%
0.3%
Cash ConversionOCF / Net Profit
1.17×
0.76×
TTM Free Cash FlowTrailing 4 quarters
$34.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STOK
STOK
TBCH
TBCH
Q4 25
$13.3M
Q3 25
$-15.2M
Q2 25
$-3.1M
Q1 25
$131.8M
$40.5M
Q4 24
$-23.2M
$14.3M
Q3 24
$-23.2M
Q2 24
$-12.6M
Q1 24
$27.3M
Free Cash Flow
STOK
STOK
TBCH
TBCH
Q4 25
$13.1M
Q3 25
$-15.9M
Q2 25
$-3.5M
Q1 25
$131.7M
$40.3M
Q4 24
$-23.2M
$12.8M
Q3 24
$-24.6M
Q2 24
$-13.9M
Q1 24
$26.5M
FCF Margin
STOK
STOK
TBCH
TBCH
Q4 25
13.8%
Q3 25
-19.7%
Q2 25
-4.3%
Q1 25
83.0%
63.0%
Q4 24
-102.7%
8.8%
Q3 24
-26.1%
Q2 24
-18.1%
Q1 24
47.5%
Capex Intensity
STOK
STOK
TBCH
TBCH
Q4 25
0.3%
Q3 25
0.8%
Q2 25
0.4%
Q1 25
0.1%
0.3%
Q4 24
0.2%
1.0%
Q3 24
1.5%
Q2 24
1.6%
Q1 24
1.3%
Cash Conversion
STOK
STOK
TBCH
TBCH
Q4 25
0.76×
Q3 25
-8.84×
Q2 25
Q1 25
1.17×
Q4 24
0.71×
Q3 24
-6.79×
Q2 24
Q1 24
175.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STOK
STOK

Segment breakdown not available.

TBCH
TBCH

Europe And Middle East$71.0M75%
Asia Pacific$13.3M14%
Other$10.8M11%

Related Comparisons